LuBing
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer (NCT03258671) | LuBing | 2017-10-01 |
Track LuBing automatically
Every clearance here is in the API, with alerts when new ones post.